{"id":"W2987471862","doi":"10.1186/s12933-019-0951-9","title":"Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies","year":2019,"lang":"en","type":"article","venue":"Cardiovascular Diabetology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Servier; Sanofi; Kowa Company; Novo Nordisk; National Institute for Health and Care Research; Medicines Company; University of California, San Diego; Regeneron Pharmaceuticals; Esperion Therapeutics; GlaxoSmithKline; NIHR Imperial Biomedical Research Centre; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Dyslipidemia; Alirocumab; Medicine; Internal medicine; PCSK9; Endocrinology; Type 2 diabetes; Diabetes mellitus; Apolipoprotein B; Insulin; Cholesterol; Lipoprotein; Apolipoprotein A1; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008047654,0.0006693405,0.002043116,0.0008420171,0.000275064,0.0009127024,0.0004589722,0.0004279936,0.001573834],"category_scores_gemma":[0.006364891,0.0003657642,0.003558608,0.001735511,0.0002688701,0.000472475,0.0009263831,0.0006952484,0.00008672686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004101259,"about_ca_system_score_gemma":0.0007811628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00203545,"about_ca_topic_score_gemma":0.005392096,"domain_scores_codex":[0.9960984,0.002431265,0.0004278112,0.0004028723,0.0005084145,0.0001311099],"domain_scores_gemma":[0.9925769,0.002829818,0.002811425,0.0004382044,0.0006119367,0.0007316662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2214978,0.0005930418,0.6333929,0.00623139,0.07125279,0.0002178729,0.0001410742,0.0006584971,0.00195514,0.0003711022,0.00370663,0.05998174],"study_design_scores_gemma":[0.02773159,0.006763648,0.8951697,0.0006992512,0.06034076,0.0003728603,0.0001427532,0.001113828,0.000366226,0.0002658051,0.006962482,0.00007102828],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8769091,0.1135708,0.0009718997,0.0007147889,0.0001908731,0.0006715215,0.004511774,0.00003187423,0.002427469],"genre_scores_gemma":[0.9773402,0.01603799,0.00149222,0.0006607525,0.0002226369,0.0005146781,0.003164554,0.00001469335,0.000552186],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008047654,"threshold_uncertainty_score":0.04256058,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01772415958414966,"score_gpt":0.2509312485716827,"score_spread":0.233207088987533,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}